|Articles|July 6, 2023
Illuminating the Cellular and Molecular Response to Drug Treatment by Combining Bioenergetic Measurements with Untargeted Metabolomics
Author(s)Agilent Technologies, Inc.
This poster exhibits how combining XF and LC/MS technologies can provide deeper insight into the cellular and molecular metabolic response to drug treatment for cancer research.
Related Content
Trending on LCGC International
1
How AI and Machine Learning Are Reshaping Separations Science at HPLC 2026
2
ASMS 2026 Award Winners Highlight the Future of Mass Spectrometry
3
Hyphenated Chromatography Methods: Successes and Remaining Challenges
4
ASMS 2026: Phantom Metabolites and the Hidden Chemistry of Electrospray Ionization
5